Profile: Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care. We exhibit the capability to support key steps of the drug discovery & development process, extending from target identification through clinical trials and commercialization. We also analyze genetic variations in both normal & tumor cells, including SNPs, haplotypes, loss of heterozygosity, and gene expression levels. We also focus on marker identification and diagnostic development.